As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
Prevention of Stroke Recurrence in Patients with Embolic Stroke Study
The purpose of this study is to compare the efficacy of the thrombin inhibitor dabigatran etexilate versus aspirin for the prevention of stroke recurrence in patients with embolic stroke of undetermined source.
In order to participate you must meet the following criteria:
- Be ≥ 60 years of age.
Have at least one of the following if you are 18-59 years of age:
- Mild to moderate heart failure
- Diabetes mellitus
- Patent foramen ovale
- Prior stroke or TIA
You will be excluded from the study if any of the following criteria apply to you:
- Are at major risk cardioembolic source of embolism.
- Have a history of atrial fibrillation.
This is a partial list of inclusion and exclusion criteria.